IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 348 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $615,354 | +3350.5% | 13,566 | +2618.6% | 0.00% | – |
| Q1 2023 | $17,834 | -99.8% | 499 | -99.7% | 0.00% | -100.0% |
| Q4 2022 | $7,189,633 | +14.0% | 190,353 | +33.6% | 0.04% | +21.9% |
| Q3 2022 | $6,304,000 | +16.1% | 142,522 | -2.8% | 0.03% | +28.0% |
| Q2 2022 | $5,429,000 | +49254.5% | 146,656 | +77087.4% | 0.02% | – |
| Q3 2019 | $11,000 | -60.7% | 190 | -55.8% | 0.00% | – |
| Q2 2019 | $28,000 | +40.0% | 430 | +78.4% | 0.00% | – |
| Q1 2019 | $20,000 | -88.6% | 241 | -94.0% | 0.00% | -100.0% |
| Q1 2018 | $176,000 | -38.7% | 4,000 | -33.3% | 0.00% | -50.0% |
| Q4 2016 | $287,000 | – | 6,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |